The fibroblast growth factor and receptor system (FGF/FGFR) mediates cell communication and pattern formation in many tissue types (e.g., osseous, nervous, vascular). In those craniosynostosis syndromes caused by FGFR1-3 mutations, alteration of signaling in the FGF/FGFR system leads to dysmorphology of the skull, brain and limbs, among other organs. Since this molecular pathway is widely expressed throughout head development, we explore whether and how two specific mutations on Fgfr2 causing Apert syndrome in humans affect the pattern and level of integration between the facial skeleton and the neurocranium using inbred Apert syndrome mouse models Fgfr2+/S252W and Fgfr2+/P253R and their non-mutant littermates at P0. Skull morphological integration (MI), which can reflect developmental interactions among traits by measuring the intensity of statistical associations among them, was assessed using data from microCT images of the skull of Apert syndrome mouse models and 3D geometric morphometric methods. Our results show that mutant Apert syndrome mice share the general pattern of MI with their non-mutant littermates, but the magnitude of integration between and within the facial skeleton and the neurocranium is increased, especially in Fgfr2+/S252W mice. This indicates that although Fgfr2 mutations do not disrupt skull MI, FGF/FGFR signaling is a covariance-generating process in skull development that acts as a global factor modulating the intensity of MI. As this pathway evolved early in vertebrate evolution, it may have played a significant role in establishing the patterns of skull MI and coordinating proper skull development.
Dorey K, Amaya E (2010) FGF signalling: diverse roles during early vertebrate embryogenesis. Development 137: 3731–3742.
[3]
Cohen MJ, MacLean R (2000) Craniosynostosis: diagnosis, evaluation, and management. New York: Oxford University Press. 480 p.
[4]
Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, et al. (1995) Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9: 165–172.
[5]
Hajihosseini MK (2008) Fibroblast growth factor signaling in cranial suture development and pathogenesis. Front Oral Biol 12: 160–177.
[6]
Wang Y, Xiao R, Yang F, Karim BO, Iacovelli AJ, et al. (2005) Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development 132: 3537–48.
[7]
Wang Y, Sun M, Uhlhorn VL, Zhou X, Peter I, et al. (2010) Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+P253R mice. BMC Dev Biol 10: 22.
[8]
Aldridge K, Hill CA, Austin JR, Percival C, Martínez-Abadías N, et al. (2010) Brain phenotypes in two FGFR2 mouse models for Apert syndrome. Dev Dyn 239: 987–97.
[9]
Martínez-Abadías N, Percival C, Aldridge K, Hill CA, Ryan T, et al. (2010) Beyond the closed suture in Apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth. Dev Dyn 239: 3058–3071.
[10]
Wilke TA, Gubbels S, Schwartz J, Richman JM (1997) Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face. Dev Dyn 210: 41–52.
[11]
Olson E, Miller R (1958) Morphological integration. Chicago: University of Chicago. 376 p.
[12]
Klingenberg CP (2010) Evolution and development of shape: integrating quantitative approaches. Nat Rev Genet 11: 623–635.
[13]
Bertrand S, Camasses A, Somorjai I, Belgacem MR, Chabrol O, et al. (2011) Amphioxus FGF signaling predicts the acquisition of vertebrate morphological traits. Proc Natl Acad Sci U S A 108: 9160–9165.
[14]
Hallgrímsson B, Lieberman DE, Young NM, Parsons T, Wat S (2007) Evolution of covariance in the mammalian skull. Novartis Found Symp 284: 164–185; discussion 185–190.
[15]
Hallgrímsson B, Lieberman DE (2008) Mouse models and the evolutionary developmental biology of the skull. Int Comp Biol 48: 373–384.
[16]
Jamniczky HA, Hallgrímsson B (2009) A comparison of covariance structure in wild and laboratory muroid crania. Evolution 63: 1540–1556.
[17]
Mitteroecker P, Bookstein F (2007) The conceptual and statistical relationship between modularity and morphological integration. Syst Biol 56: 818–836.
[18]
Sperber GH (2011) The Society of Craniofacial Genetics. Abstracts of the 2010 annual meeting. Am J Med Genet Part A 155: 280–286.
[19]
Rohlf FJ, Corti M (2000) Use of two-block partial least-squares to study covariation in shape. Syst Biol 49: 740–753.
[20]
Klingenberg CP (2009) Morphometric integration and modularity in configurations of landmarks: tools for evaluating a priori hypotheses. Evol Dev 11: 405–421.
[21]
Dryden IL, Mardia KV (1998) Statistical shape analysis. Chichester: John Wiley & Sons. 376 p.
[22]
Lele S, McCulloch C (2002) Invariance, identifiability and morphometrics. JASA 971: 796–806.
[23]
Drake AG, Klingenberg CP (2008) The pace of morphological change: historical transformation of skull shape in St Bernard dogs. Proc Biol Sci 275: 71–76.
[24]
Klingenberg CP (2011) MorphoJ: an integrated software package for geometric morphometrics. Mol Ecol Resour 11: 353–357.
[25]
Wagner GP (1984) On the eigenvalue distribution of genetic and phenotypic dispersion matrices: Evidence for a non-random origin of quantitative genetic variation. J Math Biol 21: 77–95.
[26]
Young NM (2006) Function, ontogeny and canalization of shape variance in the primate scapula. J Anat 209: 623–636.
[27]
Goswami A (2006) Cranial modularity shifts during mammalian evolution. Am Nat 168: 270–280.
[28]
Porto A, Oliveira FB, Shirai LT, Conto V, Marroig G (2008) The evolution of modularity in the mammalian skull I: Morphological integration patterns and magnitudes. Evol Biol 36: 118–135.
[29]
Hallgrímsson B, Brown JJ, Ford-Hutchinson AF, Sheets HD, Zelditch ML, et al. (2006) The brachymorph mouse and the developmental-genetic basis for canalization and morphological integration. Evol Dev 8: 61–73.
[30]
Hallgrímsson B, Lieberman DE, Liu W, Ford-Hutchinson AF, Jirik FR (2007) Epigenetic interactions and the structure of phenotypic variation in the cranium. Evol Dev 9: 76–91.
[31]
Richtsmeier JT, Deleon VB (2009) Morphological integration of the skull in craniofacial anomalies. Orthod Craniofac Res 12: 149–158.
[32]
Martínez-Abadías N, Paschetta C, Azevedo S, Esparza M, González-José R (2009) Developmental and genetic constraints on neurocranial globularity: insights from analyses of deformed skulls and quantitative genetics. Evol Biol 36: 37–56.
[33]
Anderson J, Burns HD, Enriquez-Harris P, Wilkie AO, Heath JK (1998) Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet 7: 1475–1483.
[34]
Yu K, Herr AB, Waksman G, Ornitz DM (2000) Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci U S A 97: 14536–41.
[35]
Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, et al. (2001) Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci U S A 98: 7182–7187.
[36]
Ibrahimi OA, Chiu ES, McCarthy JG, Mohammadi M (2005) Understanding the molecular basis of Apert syndrome. Plast Reconstr Surg 115: 264–270.
